EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer

Yujie Zhao, Jing Yu, Xin Wang, Xu Liu, Fengli Zuo, Tianyue Xu, Leyi Tang, Ling Xiong, Li Li, Huifang Li, Xiaoting Chen, Guang Yang und 2 weitere

Advanced Science · 2026-02 · 13 (10)

DOI: 10.1002/advs.202513711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 19.11.2025. Verfasst von Yujie Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center,…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immune Checkpoint Inhibitors, Photothermal Therapy, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple‐negative breast cancer, a representative immune “cold” tumor, resists immune checkpoint blockade (ICB). A promising strategy to overcome this limitation involves combining photothermal therapy (PTT) with ICB. Here, it is demonstrated that while PTT enhances antitumor immunity by inducing immunogenic cell death (ICD), it paradoxically activates the oncogenic mTOR pathway, driving tumor immune evasion. To address this, ASPPR∩A, a mTOR inhibitor‐loaded and pH/NIR‐II‐responsive gold nanocomposite delivering localized hyperthermia and mTOR inhibition, are developed. The nanocomposite selectively targets tumor cells and efficiently converts NIR‐II light into hyperthermia upon laser irradiation. In vitro, the nanocomposite‐mediated photothermal‐mTOR dual‐therapy synergistically enhances ICD and MHC‐I antigen presentation. In murine TNBC models, this combination significantly amplifies ICD and T‐cell infiltration, and synergizes with PD‐1 blockade. Notably, this triple‐combination regimen effectively eliminates distant metastases via systemic antitumor immune response. The findings reveal the paradoxical role of PTT, establishing a photothermal‐targeted‐immune combinatorial paradigm for treating metastatic immune “cold” tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsImmune Checkpoint InhibitorsPhotothermal TherapyTOR Serine-Threonine KinasesMTOR InhibitorsImmune EvasionAnimalsMiceFemaleHumansCell Line, TumorCombined Modality TherapyGold

Stichwörter der Autor:innen

gold nanosystemimmune checkpoint blockadeimmune “cold” tumormTOR‐targeted therapyphotothermaltriple‐negative breast cancer (TNBC)

Substanzen

Immune Checkpoint InhibitorsTOR Serine-Threonine KinasesMTOR InhibitorsGold

Autor:innen und Institutionen

  • Institute of Breast Health Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, 610041, China.
  • Breast Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Laboratory of pathology, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China.
  • Research Core Facility, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
  • Animal Experimental Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.

ORCID-Profile: Xiaowei Liu

Förderung

  • National Key Research and Development Program of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province
  • National Guidance Fund on Developing Local Science and Technology for Sichuan Province
  • 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University
  • China Post-doctoral Science Foundation
  • Postdoctor Research Fund of West China Hospital, Sichuan University

Zitieren

APA

Zhao, Y., Yu, J., Wang, X., Liu, X., Zuo, F., Xu, T., Tang, L., Xiong, L., Li, L., Li, H., Chen, X., Yang, G., Jing, J., & Liu, X. (2026). Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer. Advanced Science, 13(10). https://doi.org/10.1002/advs.202513711

Vancouver

Zhao Y, Yu J, Wang X, Liu X, Zuo F, Xu T, et al. Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer. Advanced Science. 2026;13(10). doi:10.1002/advs.202513711

BibTeX
@article{Zhao2026,
  author = {Zhao, Yujie and Yu, Jing and Wang, Xin and Liu, Xu and Zuo, Fengli and Xu, Tianyue and Tang, Leyi and Xiong, Ling and Li, Li and Li, Huifang and Chen, Xiaoting and Yang, Guang and Jing, Jing and Liu, Xiaowei},
  title = {Combined Photothermal and mTOR‐Targeted Therapy Overcomes Immune Evasion and Enhances Checkpoint Blockade Efficacy in Metastatic Triple‐Negative Breast Cancer},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {10},
  doi = {10.1002/advs.202513711}
}
Kostenlos starten →